Japan OKs Cervarix As First Cervical Cancer Vaccine; Approves Wyeth's Prevnar
This article was originally published in PharmAsia News
Executive Summary
Japanese authorities gave the nation's first approval to a cervical-cancer vaccine, to U.K.-based GlaxoSmithKline's Cervarix